Susanna Mandruzzato

9PUBLICATIONS
21CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersTumour immunologyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 06, 2025
Drug-loaded nanoparticles induce immunogenic cell death and efficiently target cells from glioblastoma patients.

Ada Tushe, Elena Marinelli, Beatrice Musca

|Mar 15, 2023
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy.

Stefania Canè, Roza Maria Barouni, Marina Fabbi

|Sep 02, 2022
The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients.

Sara Magri, Beatrice Musca, Laura Pinton

|Dec 24, 2021
Sustained Accumulation of Blood-Derived Macrophages in the Immune Microenvironment of Patients with Recurrent Glioblastoma after Therapy.

Sara Magri, Beatrice Musca, Camilla Bonaudo

|Sep 18, 2020
Human MDSCs derived from the bone marrow maintain their functional ability but have a reduced frequency of induction in the elderly compared to pediatric donors.

Sara Magri, Elena Masetto, Samantha Solito

|Feb 19, 2020
Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.

Laura Pinton, Sara Magri, Elena Masetto

Pageof 2

Frequent Collaborators

2 joint publications

Giuseppe Lombardi

2 joint publications

Sara Magri

1 joint publications

Alessandro Della Puppa

1 joint publications

Stefania Canè